Efficacy of captopril in postponing nephropathy in normotensive insulin dependent diabetic patients with microalbuminuria.
about
Angiotensin converting enzyme inhibitors and angiotensin II receptor antagonists for preventing the progression of diabetic kidney diseaseA new equation to estimate glomerular filtration rateManagement of diabetic renal diseaseMorphologic features of declining renal function in type 1 diabetesClinical problem solving based on the 1999 Canadian recommendations for the management of hypertension.1999 Canadian recommendations for the management of hypertension. Task Force for the Development of the 1999 Canadian Recommendations for the Management of HypertensionRenoprotective role of ACE inhibitors in diabetic nephropathyBeneficial effects of C-peptide on incipient nephropathy and neuropathy in patients with Type 1 diabetes mellitus.Development and validation of GFR-estimating equations using diabetes, transplant and weightComparative performance of the CKD Epidemiology Collaboration (CKD-EPI) and the Modification of Diet in Renal Disease (MDRD) Study equations for estimating GFR levels above 60 mL/min/1.73 m2.Slowing the progression of renal disease in diabetic patients.Evaluation of the Chronic Kidney Disease Epidemiology Collaboration equation for estimating the glomerular filtration rate in multiple ethnicities.Blood pressure and cardiac autonomic function in relation to risk factors and treatment perspectives in Type 1 diabetes.Use of angiotensin-converting enzyme inhibitors in patients with diabetic nephropathy.ACE inhibitor intervention in Type 1 diabetes with low grade microalbuminuria.Comparison of reduction in microalbuminuria by enalapril and hydrochlorothiazide in normotensive patients with insulin dependent diabetes.Development and progression of microalbuminuria in a clinic sample of patients with insulin dependent diabetes mellitus.Diagnosis of an ectopic ureter in a girl by differential urine collection after administration of desmopressin acetate.Prevalence of abnormal urinary albumin excretion in adolescents and children with insulin dependent diabetes: the MIDAC study. Microalbinuria in Diabetic Adolescents and Children (MIDAC) research group.Evidence-based guide to slowing the progression of early renal insufficiency.Microalbuminuria as a marker of cardiovascular and renal risk in type 2 diabetes mellitus: a temporal perspective.Angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers for prevention and treatment of nephropathy associated with type 2 diabetes mellitus.Effect of deletion polymorphism of angiotensin converting enzyme gene on progression of diabetic nephropathy during inhibition of angiotensin converting enzyme: observational follow up studyPredictors of mortality in insulin dependent diabetes: 10 year observational follow up study.The diabetic patient with hypertension.Improving outcomes in diabetes and chronic kidney disease: the basis for Canadian guidelinesUric acid lowering to prevent kidney function loss in diabetes: the preventing early renal function loss (PERL) allopurinol studyDiabetic nephropathy and microalbuminuria in pregnant women with type 1 and type 2 diabetes: prevalence, antihypertensive strategy, and pregnancy outcome.Therapeutic approaches to slowing the progression of diabetic nephropathy - is less best?Endothelial dysfunction as a potential contributor in diabetic nephropathy.Progressive renal decline as the major feature of diabetic nephropathy in type 1 diabetes.Randomised controlled trial of long term efficacy of captopril on preservation of kidney function in normotensive patients with insulin dependent diabetes and microalbuminuria.Diabetic Nephropathy in Women With Preexisting Diabetes: From Pregnancy Planning to Breastfeeding.The striking effect of the Heart Outcomes Prevention Evaluation (HOPE) on ramipril prescribing in Ontario.Is screening and intervention for microalbuminuria worthwhile in patients with insulin dependent diabetes?Angiotensin-converting enzyme inhibitors in the treatment of mild arterial hypertension.Report of the Canadian Hypertension Society Consensus Conference: 5. Hypertension and diabetes.Angiotensin-converting enzyme inhibitors in diabetic nephropathy.Diabetic nephropathy. What you need to know to preserve kidney function.Diabetes and hypertension: prognostic and therapeutic considerations.
P2860
Q24244197-D2EF43D2-CF96-4909-AA52-E98DBD4A1E85Q24651973-887D7198-1C8E-41FA-BDF3-546C03A929A4Q26798436-3316DDC2-4342-4D3C-BED8-29DE986E8923Q26852459-C7813FE1-DABB-42C3-8AEC-B491DD50244AQ30499043-E3D78A50-8097-4A01-8B16-6098AA6BEC94Q30499045-837105B2-F35E-434B-A63A-BD999A90D938Q33614282-1254C9E9-1587-4A4C-A5F9-F553F99D3EDBQ33899769-DAA502F5-03FE-473C-B089-487EFDD3834DQ34021345-EBEF295A-8BDF-4D18-A0E1-BF71D0C7C327Q34079762-086FD193-EF25-4070-8BEA-10CCA697A195Q34219071-51A3A572-7999-487F-940B-8753F10C1D0DQ34452983-1BCC8063-F4AF-4562-83B0-D61DC7BECCBFQ35065524-215B24BD-1A50-4E33-8A42-080E9A951F36Q35102655-8656DBDE-097D-4DF6-B932-75D424ECD85CQ35106214-95DDCBF8-8A38-490D-A890-5014941CA89BQ35186385-47DB859A-AC57-4E97-97DE-EA10664B7E09Q35259747-161C0A44-56CA-4982-A28F-C580B26A0FA9Q35267507-E50FA856-0319-446C-9FED-5AD1194A9002Q35267527-04AB62FC-236E-46CA-BE8D-275DDCE0CA53Q35641499-C85C17B4-01FD-48DF-B104-A0F45EA69CBAQ35648485-7670242B-ED29-4E04-8EA4-1ADCF69A7729Q36289427-52B7531E-0701-43A9-B0B2-DFE9EB39D4B4Q36600164-E5467219-8007-42B4-9592-14EBAC94AD8FQ36600524-9A252E8F-CCB4-444A-8210-62E10E44D803Q36680739-F2589640-B56B-49C2-85DE-B7C2CF02B875Q36834059-BAA59849-1F1A-40F2-9EC7-3820B96C42E3Q36988877-A476B249-7453-403B-B56A-80DEE654BA97Q37278223-2CBC8A40-4512-42FA-8242-DC6B27AFE29FQ37449207-EEB08E90-34E4-459D-A9BB-F065F8D0FCAAQ37806614-AE628EE8-6E11-4AD2-A5A4-4D22E95F96C1Q38161868-71EE84D5-B754-4F65-8958-5AD8896DA8C7Q38638695-B365B699-6C97-42BA-B1E7-56FC02D2C99BQ38709341-D0E0A1C6-E4E6-4812-864E-0DD858F56594Q39731644-CD55EA02-C735-4353-BE42-0A9C71D1CA5FQ40399759-B7154032-B83D-4052-BEB0-F29980EDF24FQ40794711-BE6D1B40-8F80-49A7-A505-676DD8A608C7Q40847980-2CF9F752-112A-433A-A457-DA1964C242F2Q40852223-2914A21D-7CDD-42E0-ACDB-285353019684Q40890537-59E42C0A-BE08-42F4-80F1-C09E10FA2CEAQ41069405-3A0D9434-6F26-4470-8DED-20BDFA690AA7
P2860
Efficacy of captopril in postponing nephropathy in normotensive insulin dependent diabetic patients with microalbuminuria.
description
1991 nî lūn-bûn
@nan
1991 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
1991 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
1991年の論文
@ja
1991年論文
@yue
1991年論文
@zh-hant
1991年論文
@zh-hk
1991年論文
@zh-mo
1991年論文
@zh-tw
1991年论文
@wuu
name
Efficacy of captopril in postp ...... atients with microalbuminuria.
@ast
Efficacy of captopril in postp ...... atients with microalbuminuria.
@en
type
label
Efficacy of captopril in postp ...... atients with microalbuminuria.
@ast
Efficacy of captopril in postp ...... atients with microalbuminuria.
@en
prefLabel
Efficacy of captopril in postp ...... atients with microalbuminuria.
@ast
Efficacy of captopril in postp ...... atients with microalbuminuria.
@en
P2093
P2860
P356
P1433
P1476
Efficacy of captopril in postp ...... patients with microalbuminuria
@en
P2093
E R Mathiesen
H H Parving
P2860
P356
10.1136/BMJ.303.6794.81
P407
P50
P577
1991-07-01T00:00:00Z